Home Companies Biogen

Biogen

Most popular

Biogen

“Some Hope”: Biogen, Eisai Release Positive Phase II Results for Alzheimer’s Candidate

Biogen

Biogen, Ionis Launch $1B+ Expanded Neuro Drug Partnership, following Spinraza Success

Biogen

BMS Licenses mAb and Fusion Protein Drugs to Biogen and to Roche for up to $1B

Biogen

Biogen Raising Minority Stake in Samsung Bioepis in $672M Deal

Biogen

Biogen Mulls Tofersen’s Future after Drug Misses Phase III Trial’s Primary Endpoint in ALS

Biogen

Biogen Acquires Stroke Candidate Cirara from Remedy for $120M Upfront

Drug Discovery

Biogen Poised for Pipeline Growth, Samsung Eyes New Drug Expansion after...

Biogen

Biogen Pays Ionis $10M as Phase I/IIa Trial Launched for Alzheimer’s...

Biogen

Biogen Replenishes Eye Disease Gene Therapy Pipeline with Planned $877M Nightstar...

Businessman Holding Dollar Symbols green and red

Financing

StockWatch: Biogen Stays Flat Despite Positive 128-Week Aduhelm Data

alzheimer

Biogen

AbbVie Launches, Biogen Tweaks Alzheimer’s Collaborations

Biogen

Fujifilm Diosynth to Expand with $890M Purchase of Biogen’s Danish Biologics...

Genome Editing

Scribe Pursues CRISPR Therapies with Expanded Biogen Collaboration

Biogen

Biogen to Develop Alkermes’ MS Candidate ALKS 8700

Biogen

Biogen Shares Surge after Reversal on Alzheimer’s Candidate Aducanumab

12 3 Page 1 of 3